問卷

TPIDB > 臨床試驗主持人

臨床試驗主持人


國立台灣大學醫學院附設醫院 (在職)

胸腔外科

外科

血液腫瘤科

內科

國立臺灣大學醫學院附設癌醫中心醫院 (在職)

胸腔外科

外科

血液腫瘤科

更新時間:2023-09-19

陳晉興CHEN, JIN-SHING
  • 計畫主持人
  • 執行臨床試驗年資 22 年 9 個月

發表文獻

60

51

Lin CW, Ko HJ, Yang SM, Chen YC, Ko WC, Huang HC, Chen JS, Chang YC. Computed tomography-guided dual localization with microcoil and patent blue vital dye for deep-seated pulmonary nodules in thoracoscopic surgery. J Formos Med Assoc. 2019 Jun;118(6):979-985. doi: 10.1016/j.jfma.2019.02.005. Epub 2019 Mar 9. PMID: 30862403.

52

Hu SY, Hsieh MS, Hsu HH, Tsai TM, Chiang XH, Tsou KC, Liao HC, Lin MW, Chen JS. Corrigendum to "Correlation of tumor spread through air spaces and clinicopathological characteristics in surgically resected lung adenocarcinomas" [Lung Cancer 126 (2018) 189-193]. Lung Cancer. 2019 May;131:157-158. doi: 10.1016/j.lungcan.2019.03.005. Epub 2019 Mar 13. Erratum for: Lung Cancer. 2018 Dec;126:189-193. PMID: 30878212.

53

Tsai TM, Hung WT, Lin MW, Hsu HH, Chen JS. Computed tomography-guided dye localization prior to uniportal thoracoscopic surgery for lung nodules: A propensity score matching analysis. J Formos Med Assoc. 2019 Apr;118(4):783-789. doi: 10.1016/j.jfma.2018.09.002. Epub 2018 Sep 18. PMID: 30237041.

54

Hung MH, Chen JS, Cheng YJ. Precise anesthesia in thoracoscopic operations. Curr Opin Anaesthesiol. 2019 Feb;32(1):39-43. doi: 10.1097/ACO.0000000000000680. PMID: 30540577; PMCID: PMC6326264.

55

Lee JH, Chen HY, Hsu FM, Chen JS, Liao WY, Shih JY, Yu CJ, Chen KY, Tsai TH, Yang JC. Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors. Oncologist. 2019 Dec;24(12):e1417-e1425. doi: 10.1634/theoncologist.2019-0152. Epub 2019 May 24. PMID: 31127020; PMCID: PMC6975931.

56

Yao ZH, Liao WY, Ho CC, Chen KY, Shih JY, Chen JS, Lin ZZ, Lin CC, Yang JC, Yu CJ. Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non-small-cell lung cancer patients. Eur J Cancer. 2019 Aug;117:107-115. doi: 10.1016/j.ejca.2019.05.032. Epub 2019 Jul 3. PMID: 31279301.

57

Ma WL, Lin CC, Hsu FM, Lee JM, Chen JS, Hsieh MS, Chang YL, Chao YT, Chang CH, Chih-Hsin Yang J. Clinical Outcomes of Up-front Surgery Versus Surgery After Induction Chemotherapy for Thymoma and Thymic Carcinoma: A Retrospective Study. Clin Lung Cancer. 2019 Nov;20(6):e609-e618. doi: 10.1016/j.cllc.2019.06.011. Epub 2019 Jul 10. PMID: 31377141.

58

Lin YT, Chen JS, Liao WY, Ho CC, Hsu CL, Yang CY, Chen KY, Lee JH, Lin ZZ, Shih JY, Yang JC, Yu CJ. Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations. Int J Cancer. 2019 Jun 1;144(11):2887-2896. doi: 10.1002/ijc.32025. Epub 2019 Jan 5. PMID: 30485437.

59

Hung CT, Tsai TF, Chen JS, Hsieh MS. Thymoma-associated multiorgan autoimmunity. BMJ Case Rep. 2019 Aug 2;12(8):e229163. doi: 10.1136/bcr-2018-229163. PMID: 31377716; PMCID: PMC6685366.

60

How CH, Lin CW, Lin YC, Young TH, Chen KC, Chen JS. Evaluation of pleurodesis by poly-ε-caprolactone (PCL) gel in an animal model using New Zealand white rabbits. Asian J Surg. 2019 Mar;42(3):495-500. doi: 10.1016/j.asjsur.2018.07.001. Epub 2018 Aug 10. PMID: 30104088.